Dimensional Fund Advisors LP Buys 700,788 Shares of MetLife, Inc. (NYSE:MET)

Dimensional Fund Advisors LP grew its position in MetLife, Inc. (NYSE:METFree Report) by 20.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,053,851 shares of the financial services provider’s stock after buying an additional 700,788 shares during the period. Dimensional Fund Advisors LP’s holdings in MetLife were worth $268,090,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of MET. Criterion Capital Advisors LLC acquired a new position in shares of MetLife in the 4th quarter valued at $26,000. Planned Solutions Inc. purchased a new stake in MetLife in the fourth quarter valued at approximately $28,000. Quintet Private Bank Europe S.A. acquired a new position in MetLife in the 3rd quarter worth approximately $28,000. Tennessee Valley Asset Management Partners acquired a new stake in MetLife during the 4th quarter valued at approximately $34,000. Finally, Headlands Technologies LLC purchased a new stake in shares of MetLife in the 3rd quarter valued at $36,000. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Insider Buying and Selling at MetLife

In related news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares in the company, valued at approximately $4,174,893.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

MET has been the subject of a number of recent research reports. Piper Sandler reduced their price objective on MetLife from $85.00 to $82.00 and set an “overweight” rating for the company in a research note on Monday, May 6th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research report on Saturday. UBS Group dropped their target price on MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research report on Monday, February 5th. Keefe, Bruyette & Woods lowered their price target on MetLife from $87.00 to $86.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 7th. Finally, Wells Fargo & Company reduced their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Friday. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $78.85.

View Our Latest Stock Analysis on MET

MetLife Trading Down 0.4 %

Shares of MET opened at $72.41 on Tuesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.58. The firm has a 50-day moving average price of $71.92 and a 200 day moving average price of $67.93. MetLife, Inc. has a 12-month low of $48.95 and a 12-month high of $74.68. The firm has a market capitalization of $51.49 billion, a P/E ratio of 24.88, a P/E/G ratio of 0.57 and a beta of 1.03.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.83 EPS for the quarter, meeting the consensus estimate of $1.83. The firm had revenue of $17.02 billion for the quarter, compared to analyst estimates of $17.73 billion. MetLife had a net margin of 3.50% and a return on equity of 20.39%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.52 EPS. Sell-side analysts forecast that MetLife, Inc. will post 8.72 EPS for the current year.

MetLife declared that its board has initiated a share buyback plan on Wednesday, May 1st that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 6% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

MetLife Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be issued a $0.545 dividend. This is a positive change from MetLife’s previous quarterly dividend of $0.52. This represents a $2.18 annualized dividend and a yield of 3.01%. The ex-dividend date of this dividend is Monday, May 6th. MetLife’s payout ratio is 74.91%.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.